James Renwick McCullough

Insider Reports History

Entity
Individual
Location
C/O Renalytix Plc, Finsgate, 5 7 Cranwood Street, London, United Kingdom
Signature
/s/ Katie Kazem, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Renwick McCullough:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Renalytix plc Chief Executive Officer, Director Ordinary Shares 2.55M $639K $0.25 Jul 1, 2023 By The McCullough 2020 Irrevocable Trust
Renalytix plc Chief Executive Officer, Director Ordinary Shares 192K $48K $0.25 Jul 1, 2023 Direct
Renalytix plc Chief Executive Officer, Director Employee Stock Option (right to buy) 875K Jul 6, 2023 Direct

Insider Reports Filed by James Renwick McCullough

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNLX Renalytix plc Jul 6, 2023 1 $0 4 Jul 7, 2023 Chief Executive Officer, Director
RNLX Renalytix plc Jul 1, 2023 0 $0 3 Jul 3, 2023 Chief Executive Officer, Director